Low-dose aspirin increases aspirin resistance in patients with coronary artery disease

American Journal of Medicine

Volumn 118, Issue 7, 2005, Pages 723-727

  Lee, Pui Yin ^a   Chen, Wai Hong ^a   Ng, William ^a   Cheng, Xi ^a   Kwok, Jeanette Yat Yin ^a   Tse, Hung Fat ^a   Lau, Chu Pak ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aspirin; Coronary disease; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; HEMOGLOBIN;

ADULT; AGED; ANALYTIC METHOD; ANEMIA; ARTICLE; ASSAY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; DRUG RESPONSE; FEMALE; HEALTH CENTER; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; PATIENT; PATIENT REFERRAL; PREDICTION; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE DYSFUNCTION;

AGED; ASPIRIN; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES;

EID: 21244446907     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.03.041     Document Type: Article

References (17)

1. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
2. K. Andersen, M. Hurlen, H. Arnesen, I. Seljeflot Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease Thromb Res. 108 2002 37 42
3. W.H. Chen, P.Y. Lee, W. Ng, H.F. Tse, C.P. Lau Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J Am Coll Cardiol. 43 2004 1122 1126
4. J.W. Eikelboom, J. Hirsh, J.I. Weitz, M. Johnston, Q. Yi, S. Yusuf Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655
5. M.R. Mueller, A. Salat, P. Stangl Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty Thromb Haemost. 78 1997 1003 1007
6. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol. 41 2003 961 965
7. C. Patrono, B. Coller, G.A. FitzGerald, J. Hirsh, G. Roth Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 234S 264S
8. P.A. Gum, K. Kottke-Marchant, E.D. Poggio Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol. 88 2001 230 235
9. J.C. Wang, D. Aucoin-Barry, D. Manuelian Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA Am J Cardiol. 92 2003 1492 1494
10. S.V. Rao, J.G. Jollis, R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
11. N. Zimmermann, A. Wenk, U. Kim Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery Circulation 108 2003 542 547
12. R.G. Hart, A.D. Leonard, R.L. Talbert Aspirin dosage and thromboxane synthesis in patients with vascular disease Pharmacotherapy 23 2003 579 584
13. C.M. Helgason, K.M. Bolin, J.A. Hoff Development of aspirin resistance in persons with previous ischemic stroke Stroke 25 1994 2331 2336
14. M.J. Quinn, H.D. Aronow, R.M. Califf Aspirin dose and six-month outcome after an acute coronary syndrome J Am Coll Cardiol. 43 2004 972 978
15. E.J. Topol, D. Easton, R.A. Harrington Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease Circulation 108 2003 399 406
16. R.J. Peters, S.R. Mehta, K.A. Fox Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 108 2003 1682 1687
17. A. Malinin, M. Spergling, B. Muhlestein, S. Steinhubl, V. Serebruany Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer Blood Coagul Fibrinolysis 15 2004 295 301